Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

NCT04963283 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Adenocarcinoma
Colon Cancer
Colon Adenocarcinoma
Rectum Cancer
Rectal Cancer
Rectal Adenocarcinoma
Colorectal Cancer

Interventions

DRUG: Cabozantinib
DRUG: Nivolumab

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]